Neurocrine (NBIX) Q4 2025 Earnings Call Transcript
Source: Motley Fool
2026-02-11 20:59:11 ET
Image source: The Motley Fool.
Wednesday, Feb. 11, 2026 at 4:30 p.m. ET
Need a quote from a Motley Fool analyst? Email pr@fool.com
Neurocrine Biosciences Inc.
NASDAQ: NBIX
NBIX Trading
1.27% G/L:
$129.94 Last:
6,822 Volume:
$130.40 Open:
NBIX Latest News
March 06, 2026 05:00:00 pm
BetterInvesting(TM) Magazine Update on Equifax Inc. (NYSE: EFX) and Neurocrine Bio In. (NASDAQ: NBIX)
February 26, 2026 09:35:00 am
From Lab to Clinic: Five CNS Companies Advancing Neuroscience Treatments
NBIX Stock Data
$13,828,183,256
94,919,824
0.84%
315
N/A
Pharmaceuticals
Healthcare
US
San Diego
